About
Carthera is a clinical-stage medtech company based in France, founded in 2010 by Professor Alexandre Carpentier. The company focuses on developing innovative ultrasound-based medical devices to treat severe brain disorders, including glioblastoma and other central nervous system diseases. Carthera's flagship product is the SonoCloud, an intracranial implant that uses low intensity pulsed ultrasound to temporarily open the blood-brain barrier. This technology enhances the delivery of chemotherapy drugs directly to brain tumors, improving treatment efficacy. The company is actively involved in clinical trials and research collaborations to validate and expand the applications of its ultrasound technologies. Carthera serves patients with severe brain diseases, medical institutions, and healthcare providers seeking non-invasive treatment options. The company is committed to advancing its innovative solutions and regularly participates in scientific research and medical conferences.
Technologies
Keywords
Company Information
- Employees29
- Founded2010
- Annual Revenue$5200000
- Total Funding$81107541
Location
Lyon, Rhone-Alpes, France
